We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current IXI market cap is 8.8M. The company's latest EPS is GBP -0.0216 and P/E is -4.40.
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 9.53M | 9.19M | 8.64M | 6.67M | 5.77M |
| Operating Income | 836k | 1.15M | 800k | -1.35M | -2.1M |
| Net Income | 952k | 1.51M | 1.03M | -1.18M | -2M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 12.1M | 14.26M | 14.66M | 12.99M | 11.19M |
| Total Liabilities | 2.98M | 2.78M | 2.16M | 1.56M | 1.72M |
| Total Equity | 9.12M | 11.48M | 12.49M | 11.43M | 9.46M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 1.92M | 613k | 1.42M | 302k | -1.73M |
| Investing | -1.12M | -2.15M | -2.24M | -1.86M | -377k |
| Financing | -112k | 270k | -114k | -156k | -134k |
| Market Cap | 8.8M |
| Price to Earnings Ratio | -4.40 |
| Price to Sales Ratio | 1.53 |
| Price to Cash Ratio | 4.92 |
| Price to Book Ratio | 0.93 |
| Dividend Yield | - |
| Shares Outstanding | 92.67M |
| Average Volume (1 week) | 53.31k |
| Average Volume (1 Month) | 33.75k |
| 52 Week Change | 15.15% |
| 52 Week High | 13.00 |
| 52 Week Low | 6.45 |
| Spread (Intraday) | 1 (10%) |
| Company Name | Ixico Plc |
| Address |
4th floor london EC1A 9PN |
| Website | https://www.ixico.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
